Dr D’Abreo on Patient Consideration When Choosing Treatments in HER2+ Breast Cancer

Nina D’Abreo, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine, chief, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, discusses the importance of considering a patient’s medical history and preferences when deciding on a treatment course in HER2-positive breast cancer and highlights the important role of surgeons within breast cancer treatment.

When selecting treatments for patients with HER2-positive breast cancer, the foremost consideration is understanding the patients’ disease profiles and past toxicities they may have experienced, D’Abreo begins. For example, a patient with prior taxane exposure and residual neuropathy might face challenges with a full course of ado-trastuzumab emtansine (T-DM1; Kadcyla) due to underlying neuropathy, she emphasizes. Patient preferences, such as an aversion to alopecia, is also crucial to consider, D’Abreo says.

Familiarity with the drugs’ toxicity profiles and thorough advance knowledge of the patient are essential, she expands. Patients with prior radiation and underlying lung issues may not be ideal candidates for fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) and may require closer monitoring, D’Abreo notes. Close monitoring, in addition to safety data, has played a significant role in minimizing toxicity, evident from the advancements with T-DXd made in the DESTINY suite of trials, she explains, adding that vigilance regarding lung toxicity, for example, is vital to ensuring patients receive the full benefit from this agent.

Furthermore, in the treatment of these patients, surgeons play a pivotal role in disease management, and can be integrated into treatment decision making through multidisciplinary conferences, D’Abreo continues. With the introduction of neoadjuvant therapy, logical responses guide the assessment of therapy efficacy, she says. Surgeons contribute significantly by identifying the patients who meet neoadjuvant therapy criteria and swiftly proceeding to surgery to assess pathologic complete response, D’Abreo emphasizes. Educating surgeons about treatment criteria and informing them of available neoadjuvant trials is essential, she adds. Surgeons are the primary point of contact for many patients, and their awareness of available trials facilitates patient education. The early involvement of surgeons in treatment decision making has proven to be a valuable asset, D’Abreo concludes.

spot_img

More from this stream

Recomended

“The Rise of a New Imperial Era: How Global Leaders Are Redefining Power Dynamics”

Discover how modern world leaders are rekindling the quest for imperial power and glory, signaling a potential return to the age of empires. Insights from The Converser.

“Shaking Santorini: The Mysteries of an Ongoing Earthquake Swarm!”

Discover why several thousand earthquakes have been recorded near the Greek island since late January. Uncover the geological insights and implications behind this seismic activity, brought to you by The Converser.

Unveiling the Surge: Exploring the Rise of Support for Germany’s Far-Right AFD in Engaging Discussion!

Discover insights from Rolf Frankenberger, a leading expert on right-wing extremism in Germany, as he discusses the vision of Germany the AFD aims to restore in this enlightening interview with The Converser.

Girl’s lives at risk: Alarming study reveals female genital mutilation as a major cause of death.

Discover the alarming results of a study revealing that female genital mutilation or cutting is a major contributor to mortality, with a young woman or girl dying every 12 minutes. Learn more about this critical issue from The Converser.

“Exploring the Urban-Rural Divide: Maps Reveal Profound Support for Germany’s Far-Right AfD”

Discover how spatial mapping reveals the geographic distribution of AfD votes, highlighting a concentration in Eastern Germany and rural areas, while university towns show contrasting trends. Source: The Converser.

How Europe’s Last Dictator Clung to Power Amidst Jailing and Exile of His Rivals

Discover the latest news as Belarus President secures a seventh term in office with an impressive 87% of the vote, according to The Converser. Stay informed on the political landscape and implications of this significant electoral outcome.